ATE524442T1 - Antiproliferative wirkstoffe - Google Patents

Antiproliferative wirkstoffe

Info

Publication number
ATE524442T1
ATE524442T1 AT02704961T AT02704961T ATE524442T1 AT E524442 T1 ATE524442 T1 AT E524442T1 AT 02704961 T AT02704961 T AT 02704961T AT 02704961 T AT02704961 T AT 02704961T AT E524442 T1 ATE524442 T1 AT E524442T1
Authority
AT
Austria
Prior art keywords
active ingredients
agents
antiproliferative active
certain
antiproliferative
Prior art date
Application number
AT02704961T
Other languages
English (en)
Inventor
Washington AYUKO
Michael Tisdale
Eric Lattmann
Original Assignee
Epx Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epx Res Ltd filed Critical Epx Res Ltd
Application granted granted Critical
Publication of ATE524442T1 publication Critical patent/ATE524442T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/88—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having the nitrogen atom of at least one of the carboxamide groups further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/66—Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02704961T 2001-03-13 2002-03-12 Antiproliferative wirkstoffe ATE524442T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0106137A GB2373246B (en) 2001-03-13 2001-03-13 Antiproliferative agents
PCT/GB2002/001119 WO2002072553A1 (en) 2001-03-13 2002-03-12 Antiproliferative agents

Publications (1)

Publication Number Publication Date
ATE524442T1 true ATE524442T1 (de) 2011-09-15

Family

ID=9910551

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02704961T ATE524442T1 (de) 2001-03-13 2002-03-12 Antiproliferative wirkstoffe

Country Status (10)

Country Link
US (3) US6881846B2 (de)
EP (1) EP1377551B1 (de)
AT (1) ATE524442T1 (de)
AU (1) AU2002238760B2 (de)
BR (1) BR0208101A (de)
CA (1) CA2441001C (de)
GB (3) GB2402130B (de)
NZ (1) NZ528295A (de)
WO (1) WO2002072553A1 (de)
ZA (1) ZA200307067B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9073985B2 (en) 2008-07-14 2015-07-07 The Regents Of The University Of Colorado, A Body Corporate Methods and products for treating proliferative diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4890982A (de) * 1972-03-06 1973-11-27
ZA846640B (en) * 1983-09-15 1985-04-24 Kendall & Co Microphase separated hydrogels for controlled release of bioactive materials
NL8701557A (nl) 1987-07-02 1989-02-01 Skf Ind Trading & Dev Werkwijze en inrichting voor het onderzoeken van slijtage- en wrijvingseigenschappen van loopvlakmaterialen bij glijdende wrijving.
JPH0672133B2 (ja) * 1987-12-28 1994-09-14 株式会社日本触媒 マレイミド類のアクリロニトリル溶液の輸送ならびに貯蔵方法
CA2018509A1 (en) * 1989-06-16 1990-12-16 Ryuichiro Tsumura Preparation process of n-substituted maleimides
JPH06100513A (ja) * 1992-09-25 1994-04-12 Nippon Shokubai Co Ltd マレインアミド酸エステルの製造方法

Also Published As

Publication number Publication date
US7750181B2 (en) 2010-07-06
US6881846B2 (en) 2005-04-19
GB0106137D0 (en) 2001-05-02
GB2402130A (en) 2004-12-01
BR0208101A (pt) 2004-03-02
US20040106648A1 (en) 2004-06-03
GB0418553D0 (en) 2004-09-22
GB2402129A (en) 2004-12-01
GB2373246B (en) 2005-03-02
WO2002072553A1 (en) 2002-09-19
US20050176779A1 (en) 2005-08-11
NZ528295A (en) 2005-08-26
US7049338B2 (en) 2006-05-23
GB0418552D0 (en) 2004-09-22
US20050165066A1 (en) 2005-07-28
CA2441001C (en) 2012-08-21
AU2002238760B2 (en) 2008-02-21
ZA200307067B (en) 2004-09-10
GB2402130B (en) 2005-10-26
CA2441001A1 (en) 2002-09-19
EP1377551A1 (de) 2004-01-07
EP1377551B1 (de) 2011-09-14
GB2373246A (en) 2002-09-18
GB2402129B (en) 2005-08-03

Similar Documents

Publication Publication Date Title
CO5631443A2 (es) Derivados de 7-aril-3,9-diazabiciclo (3.3.1) non-6-eno y su uso como inhibidores de renina en el tratamiento de enfermedades de hipertension, cardiovasculares o renales
DE60214179D1 (de) IMIDAZOi1,2-AöPYRIDIN-DERIVATE ZUR PROPHYLAXE UND BEHANDLUNG VON HERPES-INFEKTIONEN
ATE332301T1 (de) Antivirale pyrazolopyridin verbindungen
ATE301653T1 (de) Pyrazolopyridine
BRPI0418251B8 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
ATE300541T1 (de) Pyrazolopyridinderivate
TW200510392A (en) Chemical compounds
GB0415365D0 (en) Pyrimidine derivatives
TW200505452A (en) Chemical compounds
DE60301339D1 (de) Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen
NO20020282D0 (no) Nytt difenylpiperidinderivat
IL163608A (en) Sulfonanilides are conserved in their amino / amino acids and derivatives, their process, their pharmaceutical preparations, and their conjugated antibodies and their use in the preparation of drugs for the treatment of culture disorders
ATE274515T1 (de) Pyrazolopyridinderivate
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
ATE218560T1 (de) Wasserlösliche ähnliche verbindungen und medicament-vorstufe von paclitaxel
CY1106711T1 (el) Υποκατεστημενα παραγωγα προπανο-1,3-διαμινης και η φαρμακευτικη χρηση τους
TW200628468A (en) Bicyclononene derivatives
GB2402129B (en) Antiproliferative agents
ATE370156T1 (de) Makrolide
UY27311A1 (es) Agentes antibacterianos
DE60309926D1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
SE0004780D0 (sv) Novel compunds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties